TOCILIZUMAB AS MONOCLONAL ANTIBODY THERAPY IN OVERCOMING ACUTE RESPIRATORY DISTRESS SYNDROME IN COVID-19 PATIENTS. JIMKI [Internet]. 2022 Apr. 5 [cited 2026 May 13];9(3):92-101. Available from: https://jimki.bapin.or.id/main/article/view/488